EZH2 and cancer: In DCAF1-depleted SW620 cancer cells, ectopic EZH2 wild type and EZH2T367A phospho-blocking mutant showed low stead-state protein levels and minimal growth stimulatory effects (Supplementary Figs. 4a, b).